ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

大韓民国での精巣良性腫瘍診断・治療費用について今すぐご確認ください

料金はお問い合わせください

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは精巣良性腫瘍治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。精巣良性腫瘍治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。精巣良性腫瘍治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

大韓民国の最高の精巣良性腫瘍クリニックをご発見ください:4件の認証済み選択肢と料金

クリニックはBookimedのスマートシステムにより、5つの主要基準でのデータサイエンス分析を使用してランク付けされています。
Seoul National University Bundang Hospital (SNUBH)
Severance Hospital
Gangnam Severance Hospital
Seoul National University Hospital (SNUH)

大韓民国で精巣良性腫瘍の医学評価を受ける:今すぐ経験豊富な医師にご相談ください

すべての医師を見る
検証済み

Lee Chun Yong

50年の経験

Dr. Lee Chun-Yong is a urologist (MD, PhD). He is Honorary Director at Naeun Hospital and Honorary Professor at Hanyang University. He previously served as Director of Hanyang University Hospital and as Chair Professor and Head of Urology at Hanyang University College of Medicine.

His clinical focus includes urolithiasis (extracorporeal shock wave lithotripsy), prostate diseases (BPH, cancer, prostatitis), sexual dysfunction, vasectomy, cystitis, urinary incontinence, and voiding disorders.

Key roles and honors include Past and Honorary President of the Korean Endourological Society, Council Member of the International Urological Association, Visiting Scholar at UCLA, and Visiting Professor at the University of Tübingen. He was featured twice on EBS "Medical Experts". He received the Order of Civil Merit (Okjo Medal).

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 05/27/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

大韓民国での精巣良性腫瘍治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Are there minimally invasive treatment options for benign testicular tumors in South Korea that preserve the testicle?

South Korean hospitals provide testis-sparing surgery (TSS) for benign tumors under 2 centimeters. Specialized urologists at JCI-accredited centers perform these organ-sparing procedures. The approach preserves testosterone production and fertility. Surgeons use intraoperative frozen section analysis to confirm tumor type before proceeding with tissue preservation.

  • Surgical technique: TSS removes only the mass while saving healthy functional tissue.
  • Diagnostic confirmation: Rapid intraoperative biopsies ensure tumors are benign during the operation.
  • Clinical precision: Multidisciplinary teams at centers like Severance Hospital coordinate complex urologic care.
  • Digital integration: Hospitals like SNUBH use digital systems to plan precise microsurgical interventions.

Bookimed Expert Insight: Data shows that top-tier Seoul hospitals like SNUH and SNUBH treat over 1,500,000 patients yearly. This high volume allows surgeons to specialize intensely. Leading urologists often have experience from US or German institutions. We see a trend where these specialists prioritize fertility-sparing techniques for patients with single functional testicles or bilateral masses.

Patient Consensus: Patients note it is vital to request a second opinion if a doctor suggests full removal without discussing preservation. They highlight that asking about frozen-section pathology early in the process helps clarify if saving the testicle is possible.

How is a benign tumor definitively distinguished from a malignant one before any testicular surgery in South Korea?

South Korean urologists distinguish benign from malignant testicular tumors using high-resolution Doppler ultrasound and serum tumor markers. While imaging identifies benign traits like onion-skin appearance, a definitive diagnosis requires surgical pathology. Inguinal exploration with frozen section analysis allows for testis-sparing surgery in suspicious cases.

  • Imaging gold standard: High-frequency Doppler ultrasound identifies liquid-filled cysts and internal blood flow patterns.
  • Serum tumor markers: Specialists test AFP, hCG, and LDH to detect malignant germ cell activity.
  • Clinical risk stratification: Age is critical as 75% of prepubertal cases in Korea are benign.
  • Surgical pathology: Rapid frozen section during surgery confirms the diagnosis before final tumor removal.

Bookimed Expert Insight: Leading Korean facilities like Severance Hospital and SNUH utilize highly specialized urology departments with over 2,000 doctors. Data shows these centers prioritize testis-sparing surgery when markers are normal. Large patient volumes, such as 1.6 million outpatients annually at Severance, ensure clinicians recognize rare benign patterns like epidermoid cysts.

Patient Consensus: Patients note it is important to check if the mass is inside or outside the testicle on ultrasound. Many emphasize that normal blood tests do not completely rule out cancer, making surgical pathology the only final proof.

What success and safety metrics are reported for testis-sparing surgery in South Korea?

South Korean clinics report high success for testis-sparing surgery with 80–90% testosterone preservation and 100% survival for benign cases. Leading centers like Seoul National University Hospital utilize intraoperative frozen section pathology. This ensuring oncologic safety and fertility preservation for small, peripheral testicular masses.

  • Functional preservation: Natural testosterone production is maintained in 80–90% of patients.
  • Oncologic safety: Specialized centers report zero recurrence for confirmed benign lesions or teratomas.
  • Complication rates: Major hospitals record minimal risks with almost no testicular atrophy cases.
  • Fertility outcomes: Patients frequently maintain natural reproductive capacity and successful post-operative conception.

Bookimed Expert Insight: Quality signals in South Korea are tied to hospital volume. Seoul National University Hospital treats 10,700 patients daily. This massive volume allows pathologists and surgeons to master complex intraoperative frozen sections. These quick biopsies are the primary safety mechanism for avoiding unnecessary organ removal.

Patient Consensus: Patients emphasize that success means keeping their body image and fertility intact. They recommend confirming the hospital’s conversion rate from sparing surgery to full removal before the procedure.

Who are the qualified specialists, and where are they located?

Qualified urology specialists in South Korea are located primarily at major university hospitals in Seoul and Incheon. These experts manage benign testicular tumors using advanced diagnostics and fertility-preserving surgeries. Board-certified urologists at JCI-accredited facilities provide comprehensive care including scrotal ultrasound and hormonal evaluation.

  • Expert credentials: Specialists like Dr. Lee Chun Yong hold Ph.D. degrees from Hanyang University.
  • Clinical hubs: Severance Hospital and Seoul National University Hospital serve as leading Seoul centers.
  • Quality standards: Facilities maintain JCI accreditation and Newsweek World's Best Hospitals rankings.
  • Incheon access: Na-Eun Hospital provides specialized urological care outside the Seoul city center.

Bookimed Expert Insight: South Korean university hospitals prioritize massive patient volumes to maintain high expertise levels. Seoul National University Hospital alone treats over 10,000 patients daily. This scale ensures urologists see rare benign cases frequently which improves diagnostic accuracy for fertility-sparing procedures.

Patient Consensus: Patients emphasize that a testicular mass requires immediate action at a major university hospital. They note that starting fertility discussions and sperm banking early is vital before undergoing any surgical intervention.

Under what circumstances would a prosthetic testicle implant be considered for benign tumor treatment?

A prosthetic testicle implant is considered for benign tumor treatment after a surgical orchiectomy. While benign tumors are non-cancerous, large growths often necessitate full removal of the testicle. The implant restores scrotal symmetry and improves body image for patients experiencing psychosocial discomfort after surgery.

  • Surgical removal: Required when benign growths like fibromas compromise surrounding healthy tissue.
  • Cosmetic restoration: Restores symmetrical appearance and provides the physical feeling of being whole.
  • Psychological benefit: Helps maintain self-esteem by addressing body image concerns after losing a testicle.
  • Procedure timing: Surgeons can often place the silicone implant during the initial tumor removal.

Bookimed Expert Insight: While South Korea’s top-tier digital hospitals like Seoul National University Hospital serve over 10,000 patients daily, many urologists only discuss implants if the patient initiates the conversation. Patients should explicitly request an elective consultation with specialists like Dr. Lee Chun Yong before their orchiectomy. This ensures the surgeon assesses scrotal skin health early enough to allow for immediate placement during the primary surgery, avoiding a second operation later.

Patient Consensus: Patients note that while implants offer good symmetry, they often feel firmer and stay in a fixed position compared to natural tissue. Many recommend asking about the specific size and feel before surgery to ensure expectations match the final cosmetic result.

What type of follow-up and imaging is recommended after testis-sparing surgery in South Korea?

South Korean protocols for benign testicular tumors prioritize ultrasound-based surveillance to preserve fertility and monitor tissue health. Follow-up typically occurs every 3 to 6 months during the first year. After 12 months, stable patients generally transition to annual screenings with physical examinations and scrotal imaging.

  • Imaging gold standard: Scrotal ultrasound monitors remaining tissue for recurrence or healing without radiation.
  • Surveillance frequency: Visits occur every 3–6 months initially, then move to annual check-ups.
  • Tumor markers: Doctors monitor AFP and hCG levels to confirm the absence of malignancy.
  • Pediatric monitoring: Children undergo additional assessments for normal growth and hormonal developmental progress.

Bookimed Expert Insight: Leading centers like Seoul National University Hospital (SNUH) and Severance Hospital utilize advanced electronic data systems to track long-term recovery metrics. While some centers treat over 1,500,000 patients annually, urology departments maintain high safety through digital tracking. This technology ensures that even for benign cases, vital imaging milestones are never missed during long-term follow-up.

Patient Consensus: Patients note that the first visit usually focuses on wound healing. They emphasize that while surveillance is strict early on, it becomes much lighter once pathology confirms a benign result.

無料相談を受ける

最適な連絡方法をお選びください